Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-22

Clinical Trial Update: Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT [NA]

View source ↗

Summary

A non-inferiority randomized trial is evaluating home-based versus hospital-based anti-VEGF treatment for diabetic macular edema and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anti-VEGF therapy

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Diabetic Macular Edema | NA | Status: RECRUITING